# Transcranial Magnetic Stimulation + Language Therapy to Treat Mild Aphasia

> **NCT06842745** · PHASE2 · RECRUITING · sponsor: **University of Pennsylvania** · enrollment: 24 (estimated)

## Conditions studied

- Aphasia
- Stroke
- Aphasia Following Cerebral Infarction
- Aphasia, Acquired

## Interventions

- **DEVICE:** Transcranial Magnetic Stimulation (TMS)
- **BEHAVIORAL:** Speech-Language Therapy (SLT)

## Key facts

- **NCT ID:** NCT06842745
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-11
- **Primary completion:** 2026-08-31
- **Final completion:** 2026-08-31
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-03-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06842745

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06842745, "Transcranial Magnetic Stimulation + Language Therapy to Treat Mild Aphasia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06842745. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*